Search
for
Sort by
Research 211–240 of 1000+
- Immune cell regulation of the hair cycle
- Primary cicatricial alopecias
- Lab Quality Management and Methodology
- Wound Healing: A Cellular Perspective
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- ADVANCES IN PSORIASIS THERAPY
- Cutaneous drug reactions
- Alopecia areta: a review
- British Hair and Nail Society
- A patient with diffuse hair loss
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
- LUPUS ERYTHEMATOSUS AND THE SKIN
- British Society for Dermatopathology: Summaries of Papers
- General Dermatology
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Autoimmune Hair Loss Induced by Alloantigen in C57BL/6 Mice.
- Alopecia areata
- Special Stains and Immunohistochemical Stains in Hair Pathology
- Skin
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Lupus panniculitis clinically simulating alopecia areata
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Female-patterned alopecia in teenage brothers with unusual histologic features
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations